These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7081613)

  • 1. [Control of the effect of treatment in late threatened abortions using the DU-1 Dynamo-uterograph].
    Tsenov D; Penev I; Tsankov Ts
    Akush Ginekol (Sofiia); 1982; 21(1):11-5. PubMed ID: 7081613
    [No Abstract]   [Full Text] [Related]  

  • 2. [Magnesium sulfate treatment of threatened late abortions and premature labor].
    Penev I; Pavlova F; Naumov I; Shtereva K; Vlasova D
    Akush Ginekol (Sofiia); 1981; 20(4):265-8. PubMed ID: 7304843
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hysterographic studies of uterine contractile activity during partusysten treatment of threatened late abortion and premature labor].
    Vinnyts'kyĭ OI
    Pediatr Akus Ginekol; 1979; (4):40-1. PubMed ID: 514659
    [No Abstract]   [Full Text] [Related]  

  • 4. [The DU-1 dynamo-uterograph].
    Chikhetov VV; Aleksandrov OE; Khasin AZ
    Med Tekh; 1989; (1):54. PubMed ID: 2739551
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tocolytic treatment of pregnant women with threatened abortions and preterm labor in the second and third trimesters of pregnancy with magne B6 (a preliminary communication)].
    Marinov B; Damianov L; Tsache K; Atanasova B
    Akush Ginekol (Sofiia); 1999; 38(1):74-6. PubMed ID: 11965731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Magnesium and pregnancy].
    Yamasaki M
    Clin Calcium; 2012 Aug; 22(8):1205-10. PubMed ID: 22846356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of premature labour and antagonization of the side effects of tocolytic therapy with verapamil (author's transl)].
    Gummerus M
    Z Geburtshilfe Perinatol; 1977 Oct; 181(5):334-40. PubMed ID: 605642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of vaginal progesterone on pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy.
    Palagiano A; Bulletti C; Pace MC; DE Ziegler D; Cicinelli E; Izzo A
    Ann N Y Acad Sci; 2004 Dec; 1034():200-10. PubMed ID: 15731312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Control of uterine contraction with tocolytic agents (ritodrine). 2. Use in cases of threatened abortion, cervical incontinence and gynecologic surgery in pregnancy].
    Colombo PA; Pittino R; Pascalino MC; Quaranta S
    Ann Ostet Ginecol Med Perinat; 1981; 102(6):431-40. PubMed ID: 7337350
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hormonal treatment of spontaneous abortions--our experience].
    Katsulov A; Donchev V
    Akush Ginekol (Sofiia); 1985; 24(6):1-4. PubMed ID: 4091205
    [No Abstract]   [Full Text] [Related]  

  • 11. [Characteristics of the course and management of pregnancy in placenta praevia].
    Sidorova IS; Botvin MA; Khachapuridze VV
    Sov Med; 1989; (6):108-11. PubMed ID: 2799480
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative evaluation of various methods of treatment of threatened abortion in patients with uterine myoma].
    Vasil'chenko NP; Turkin VN; Volkov VV
    Akush Ginekol (Mosk); 1990 Jun; (6):47-50. PubMed ID: 2221266
    [No Abstract]   [Full Text] [Related]  

  • 13. [Action of orciprenaline administrated orally in threatened abortion].
    Uranga Imaz FA; Goñi JA; Selva A
    Obstet Ginecol Lat Am; 1973; 31(9-10):352-8. PubMed ID: 4806747
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of spontaneous abortions with the preparation, Provera].
    Despodova D; Georgieva M; Katsarova M
    Akush Ginekol (Sofiia); 1979; 18(6):457-61. PubMed ID: 525724
    [No Abstract]   [Full Text] [Related]  

  • 15. [The use of ritodrine in obstetrics].
    Bompiani A; Liverani A; Romanini C
    Ann Ostet Ginecol Med Perinat; 1980; 101(1):5-31. PubMed ID: 6994568
    [No Abstract]   [Full Text] [Related]  

  • 16. [Our experience in treating spontaneous abortions using the preparation Supradyn-N].
    Milchev N; Krŭsteva M; Piperkov T; Malinova M; Pekhlivanov B
    Akush Ginekol (Sofiia); 1987; 26(4):18-23. PubMed ID: 3674317
    [No Abstract]   [Full Text] [Related]  

  • 17. [Tocolytic substituent treatment with Magnerot in threatened abortions and premature labor from the 16th to the 36th gestational week].
    Damianov L; Negentsov N; Ivanov S; Novachkov V; Tsachev K
    Akush Ginekol (Sofiia); 1995; 34(3):78-81. PubMed ID: 8743863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Attempted gestanone therapy of imminent and habitual abortions].
    Zymek-Giermańska T; Sward J
    Wiad Lek; 1965 Sep; 18(18):1447-50. PubMed ID: 5840901
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hysterographic studies in complex treatment of pregnant women with threatened abortion].
    Aivazian TA
    Vopr Okhr Materin Det; 1974 Nov; 19(11):67-70. PubMed ID: 4439743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between uterine contractions and serum magnesium levels in patients treated for threatened preterm labour with intravenous magnesium sulphate.
    Lurie S; Gur D; Sadan O; Glezerman M
    J Obstet Gynaecol; 2004 Apr; 24(3):247-8. PubMed ID: 15203617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.